Skip to content

Canadian Adult Congenital Heart Disease Intervention Registry

The Canadian Registry for Adults With Congenital Heart Disease Interventions

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04288596
Acronym
C-ACHDiR
Enrollment
9000
Registered
2020-02-28
Start date
2020-04-01
Completion date
2030-04-01
Last updated
2020-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Septal Defect, Coarctation of Aorta, Fontan, Patent Foramen Ovale, Percutaneous Pulmonary Valve Implantation, Tetralogy of Fallot, Transposition of Great Vessels

Brief summary

The ACHDi Registry study will create a foundational database for adult congenital heart disease interventions. This Pan-Canadian Registry will collect clinical and patient-reported information that will enable the evaluation of care processes and outcomes in five most common ACHDi interventions by enabling prospective and retrospective registry-based studies to answer important clinical practice and policy-relevant questions.

Detailed description

The goal of this study is to establish a rigorously developed registry to enable an impactful research agenda in adults with congenital heart disease interventions (ACHDi). The clinical and patient-reported information captured in the Registry will allow researchers to evaluate care processes and outcomes in five most common ACHDi interventions including transcatheter closure of atrial septal defects, closure of patent foramen ovale, coarctation of aorta stenting, percutaneous pulmonary valve implantation, and complex catheterization. In 2019, we established the Canadian Research Network for ACHD Interventions (CRN-ACHDi), a national ACHD research network bringing together researchers, providers, patients, and policymakers from 4 provinces (Alberta, British Columbia, Ontario and Quebec) to improve patient experiences and outcomes through i) a national registry with modern data platform; ii) a rigorously established national research priorities agenda; and iii) a strong collaborative and multidisciplinary research environment. The C-ACHDi Registry will provide opportunities for researchers to ask clinical practice and policy-relevant research questions that are supported by high quality data. In addition, it will provide an opportunity for patients to contribute data for meaningful and high quality clinical and translational research. The C-ACHDi Registry will provide a base for conducting registry-based studies (e.g., prospective experimental, prospective and retrospective observational) in the future as well as a foundation for benchmark and quality improvement activities.

Interventions

OTHERParticipants undergoing ACHD intervention

Participants will receive standard of care for their ACHD intervention.

Sponsors

University Health Network, Toronto
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 110 Years
Healthy volunteers
No

Inclusion criteria

* participants must be 18 years or older referred for intervention for one of five ACHD conditions including diagnostic catheterization for complex ACHD patients (Tetralogy of Fallot, Fontan, and transposition of the great vessels, single ventricle, truncus arteriosus); transcatheter closure of atrial septal defects; transcatheter closure of patent foramen ovale; coarctation of aorta stenting, and percutaneous pulmonary valve implantation.

Exclusion criteria

* participants below the age of 18 * participants residing outside of Canada

Design outcomes

Primary

MeasureTime frameDescription
the number of subjects enrolledbaselineThis is an observational registry. The primary outcome is the number of subjects enrolled who are undergoing ACHD intervention.

Countries

Canada

Contacts

Primary ContactLusine Abrahamyan, MD, PhD
lusine.abrahamyan@theta.utoronto.ca416-634-8782
Backup ContactEric Horlick, MD
eric.horlick@uhn.ca

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026